Physiology and potential application of NKT cells: A minireview

Chinese Journal of Physiology

Volumn 52, Issue 5, 2009, Pages 275-279

  Yeh, Jiun Yih ^a   Yen, Ming Shien ^a   Lo, Wei Yu ^c   Chao, Kuan Chong ^a   Yuan, Chiou Chung ^a   Juang, Chi Mou ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Healthbanks Biotechnology Corporation Ltd   (Taiwan)

Author keywords

Anticancer immunotherapy; Nkt cells

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ASTHMA; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL SURFACE; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNITY; LIVER INJURY; MULTIPLE MYELOMA; NATURAL KILLER T CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

EID: 73349121267     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2009.AMH058     Document Type: Review

References (38)

1. Bach, J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542, 1994.
2. + natural killer T cells in the large intestine. Eur. J. Immunol. 31: 3361-3369, 2001.
3. Bendelac, A., Rivera, M.N., Park, S.H. and Roark, J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562, 1997.
4. Brozovic, S., Nagaishi, T., Yoshida, M., Betz, S., Salas, A., Chen, D., Kaser, A., Glickman, J., Kuo, T., Little, A., Morrison, J., Corazza, N., Kim, J.Y., Colgan, S.P., Young, S.G., Exley, M. and Blumberg, R.S. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10: 535-539, 2004.
5. Chang, C.S., Brossay, L., Kronenberg, M. and Kane, K.P. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J. Exp. Med. 189: 483-491, 1999.
6. Dhodapkar, K.M., Cirignano, B., Chamian, F., Zagzag, D., Miller, D.C., Finlay, J.L. and Steinman, R.M. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion. Int. J. Cancer. 109: 893-899, 2004.
7. Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S., Dhodapkar, K.M. and Krasovsky, J. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 197: 1667-1676, 2003.
8. Di Santo, J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24: 257-286, 2006.
9. Fuss, I.J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R.S., Mannon, P. and Strober, W. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113: 1490-1497, 2004.
10. Giaccone, G., Punt, C.J.A., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B.M.E., Scheper, R.J., van der Vliet, H.J.J., van den Eertwegh, A.J.M., Roelvink, M., Beijnen, J., Zwierzina, H. and Pinedo, H.M. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8: 3702-3709, 2002.
11. Godfrev, D.I. and Berzins, S.P. Control points in NKT-cell development. Nat. Rev. Immunol. 7: 505-518, 2007.
12. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. and Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237, 2004.
13. Godó, M., Sessler, T. and Hamar, P. Role of invariant NKT (iNKT) in systemic lupus erythematosus. Curr. Med. Chem. 15: 1778-1787, 2008.
14. + -like thymocytes in the NOD mouse. Eur. J. Immunol. 26: 2989-2998, 1996.
15. Grose, R.H., Thompson, F.M., Baxter, A.G., Pellicci, D.G. and Cummins, A.G. Deficiency of invariant NKT cells in Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 52: 1415-1422, 2007.
16. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056, 1998.
17. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S. and Strober, W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629-638, 2002.
18. + T cells, in mice. Immunology 113: 371-377, 2004.
19. Iwai, T., Tomita, Y., Okano, S., Shimizu, I., Yasunami, Y., Kajiwara, T0., Yoshikai, Y., Taniguchi, M., Nomoto, K. and Yasui, H. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. J. Immunol. 177: 8400-8409, 2006.
20. α 24 NKT cells. Cancer Res. 59: 5102-5105, 1999.
21. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900, 2005.
22. + regulatory T cells. J. Immunol. 177: 3695-3704, 2006.
23. Matsuda, J.L., Naidenko, O.V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.R., Koezuk, Y. and Kronenberg, M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754, 2000.
24. Munz, C., Steinman, R.M. and Fujii, S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202: 203-207, 2005.
25. Oh, K., Kim, S., Park, S.H., Gu, H., Roopenian, D., Chung, D.H., Kim, Y.S. and Lee, D.S. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J. Immunol. 174: 2030-2036, 2005.
26. Ostrand-Rosenberg, S., Clements, V.K., Terabe, M., Park, J.M., Berzofsky, J.A. and Dissanayake, S.K. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-γ dependent. J. Immunol. 169: 5796-5804, 2002.
27. Panja, A., Blumberg, R.S., Balk, S.P. and Mayer, L. CD1d is involved in T cell-intestinal epithelial cell interactions. J. Exp. Med. 178: 1115-1119, 1993.
28. Ronet, C., Darche, S., Leite de Moraes, M., Miyake, S., Yamamura, T., Louis, J.A., Kasper, L.H. and Buzoni-Gatel, D. NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii J. Immunol. 175: 899-908, 2005.
29. Seino, K.I., Fukao, K., Muramoto, K., Yanagisawa, K., Takada, Y., Kakuta, S., Iwakura, Y., Van Kaer, L., Takeda, K., Nakayama, T., Taniguchi, M., Bashuda, H., Yagita, H. and Okumura, K. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. U.S.A. 98: 2577-2581, 2001.
30. Taniguchi, M., Seino, K. and Nakayama, T. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4: 1164-1165, 2003.
31. Teng, M.W., Westwood, J.A., Darcy, P.K., Sharkey, J., Tsuji, M., Franck, R.W., Porcelli, S.A., Besra, G.S., Takeda, K., Yagita, H., Kershaw, M.H. and Smyth, M.J. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Res. 67: 7495-7504, 2007.
32. Terabe, M., Matsui, S., Park, J.M., Mamura, M., Noben-Trauth, N., Donaldson, D.D., Chen, W., Wahl, S.M., Ledbetter, S., Pratt, B., Letterio, J.J., Paul, W.E. and Berzofsky, J.A. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198: 1741-1752, 2003.
33. + natural killer-T cell development. Eur. J. Immunol. 29: 3313-3318, 1999.
34. Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P., Gilfillan, S. and Lantz, O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422: 164-169, 2003.
35. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100: 144-148, 2001.
36. H 2 response and in immunoglobulin E production. Science 270: 1845-1847, 1995.
37. Zeissig, S., Kaser, A., Dougan, S.K., Nieuwenhuis, E.E. and Blumberg, R.S. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1101-G1105, 2007.
38. Zeng, D., Liu, Y., Sidobre, S., Kronenberg, M. and Strober, S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J. Clin. Invest. 112: 1211-1222, 2003.